Stock SNBP PANBELA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Panbela Therapeutics, Inc.

Equities

SNBP

US69833W4042

Delayed OTC Markets
Other stock markets
 02:51:21 2024-05-17 pm EDT 		5-day change 1st Jan Change
0.44 USD -8.32% Intraday chart for Panbela Therapeutics, Inc. +15.88% -97.60%
12:25pm North American Morning Briefing : The "Everything -2- DJ
May. 15 Transcript : Panbela Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : The "Everything -2-
DJ
Transcript : Panbela Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024
Panbela Provides Business Update and Reports Q1 2024 Financial Results
AQ
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
GL
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
GL
Certain Stock Options of Panbela Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.
CI
Certain Warrants of Panbela Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.
CI
Certain Common Stock of Panbela Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.
CI
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
GL
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
GL
Panbela Therapeutics, Inc. Announces Interim Data Analysis for its Ongoing ASPIRE Trial Pushed to First Quarter of 2025
CI
Panbela Announces Poster Presentation at American Association for Cancer Research
AQ
Panbela Announces Poster Presentation at American Association for Cancer Research
GL
Panbela Announces Poster Presentation At American Association for Cancer Research
CI
Panbela Announces Transfer to OTCQB Market
GL
Transcript : Panbela Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024
Panbela Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
AQ
Panbela Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNBP Stock
  4. News Panbela Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW